Breaks Categories: Stock Spotlights

FridayApr 06, 2018 3:29 pm

HempNewsBreaks – EVIO, Inc. (EVIO) Cannabis Testing Services Ensure Safety, Analyze Potency

EVIO (OTCQB: EVIO), a life sciences and cannabis testing company, provides laboratory testing to ensure that consumers receive products that meet stringent standards of healthful quality. An article discussing the company’s services reads: “The company plans to reach a total of 18 laboratories in the United States by the end of the year. In the meantime, clients can bring plant samples into the Oregon-based company’s labs in Colorado or four other states along the East and West Coasts or ask a lab representative to make an on-site visit for random sampling. The lab will visually inspect the plants for signs…

Continue Reading

FridayApr 06, 2018 3:23 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Technology Could Revolutionize Smokeless Tobacco

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) revolutionary DehydraTECH™ technology has proven to be effective in cannabinoid delivery and is now undergoing testing for nicotine. An article discussing the company reads: “Lexaria is now looking to out-license its DehydraTECH to third-party partners in the tobacco industry. These partnerships could pave the way for a healthier smoke-free option for the one billion smokers worldwide. Lexaria is the only company in the world that holds a patent for this oral technology, including the pill. A new U.S. patent award protects this nicotine delivery system, creating a path for what could be the world’s…

Continue Reading

FridayApr 06, 2018 3:09 pm

HempNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Employs Seasoned Executives to Shape Diverse Portfolio

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), along with its subsidiaries, has been strengthening its scientific, legal and accounting teams with experienced leadership additions. An article discussing the company reads: “Together, the team is building a diversified portfolio of companies. Through this portfolio, it is helping to market high quality, medicinal-grade cannabis products with great promise for both human and veterinary use as Canada nears openness to all aspects of marijuana use later this year. Liberty Leaf continues seeking out productive, revenue-generating cannabis ventures in which to invest while simultaneously building its own working capital base. Its North…

Continue Reading

ThursdayApr 05, 2018 10:12 am

HempNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues to Advance Sol-gel Drug Delivery Technology

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) believes that its unique cannabinoid-based, nose-to-brain delivery technology, which employs its Sol-gel platform, is on track to become the first of its kind to be FDA-approved. An article discussing the company’s technology reads: “PreveCeutical believes that its cannabinoid-based nose-to-brain delivery technology, using a Sol-gel platform, will be the first to gain Food and Drug Administration approval. Its water soluable, alcohol free nasal formulation which will be developed for use by adults, children and people of certain beliefs. … PreveCeutical’s groundbreaking Sol-gel delivery system displays significant benefits over other contemporary…

Continue Reading

WednesdayApr 04, 2018 3:23 pm

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Builds Diverse Portfolio in Flourishing Market Space

Marijuana Company of America (OTC: MCOA) continues to employ its diversified business plan, creating a broad range of opportunities within the flourishing cannabis market. An article discussing the company reads: “In spite of all of the short-term political gyrations, the cannabis and hemp markets continue to bloom. The demand for cannabidiol (CBD) products remains persistent, and there are many attractive opportunities in the sector. Marijuana Company of America, Inc. (OTC: MCOA) is in position to thrive in spite of any short-term contortions in the cannabis and hemp markets. The company’s low-risk, high-return profile results from its focus on industrial hemp-based…

Continue Reading

WednesdayApr 04, 2018 3:14 pm

HempNewsBreaks – Earth Science Tech, Inc. (ETST) Subsidiary Demonstrates Innovation in the Pharmaceutical Industry

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently said that its subsidiary, Canna Inno Laboratories Inc., received a grant from the Government of Québec for innovation in the pharmaceutical industry. An article discussing the company reads: “Earth Science Tech formed Canna Inno Laboratories, Inc. in 2017. Strategically headquartered in Montreal, Quebec, it allows Earth Science Tech access to Canadian government and private grants offered to companies for innovation in the pharmaceutical industry. The awarded grant will support the pre-launch process of Earth Science’s three CBD-based products. These nutraceutical products…

Continue Reading

MondayApr 02, 2018 2:31 pm

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) To Capitalize on Growing Demand for CBD-based Health Products

Market analysis company ChineseInvestors.com (OTCQB: CIIX) recently announced its plan to spinoff all hemp-related assets into a single private company. CBD Biotechnology Co. Ltd., ChineseHempOil.com, Inc. and Hemp Logic Inc. will comprise the new company. An article discussing the company’s plan reads: “The subsidiaries are well positioned to achieve significant growth. This spinoff is part of the groundwork to capitalize on the growing demand for CBD-based nutrition and health products in the U.S. and China. In January, these subsidiaries made a combined $100,000. The progress of the newly formed company will be overseen by CIIX, but the spinoff of CBD-focused…

Continue Reading

MondayApr 02, 2018 2:13 pm

HempNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Aims to Become Canada’s Premier Cannabis Brand

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is positioning itself to make the most of the Canadian cannabis industry’s anticipated spike. An article discussing the company reads: “Choom™ is targeting nothing less than becoming the premier recreational cannabis brand in Canada. With its fully-integrated business model, the company aims to be the seed-to-sale market leader in reaching the Canadian cannabis consumer. Choom™ intends to become a leading Canadian cannabis grower and will be developing a chain of high-end branded retail cannabis dispensaries in strategic Canadian jurisdictions. Choom™ retail stores will provide discriminating cannabis consumers a…

Continue Reading

ThursdayMar 29, 2018 3:43 pm

HempNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Strives to Attain GMP-compliant Procedures

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) continues to diversify its portfolio as the Canadian government prepares to legalize cannabis-infused edibles and beverages by mid-2019. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc.…

Continue Reading

ThursdayMar 29, 2018 3:38 pm

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Anticipates Additional Technology Licensing Contracts in 2018

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka recently discussed the company’s plans regarding technology licensing contracts in an audio interview. An article further discussing the company reads: “LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing. …Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration…

Continue Reading